Less STI tests in The Netherlands The number of people who were tested for a Sexually Transmitted Infection (STI) at a Dutch STI clinic has dropped for the first time in years.
RIVM and Chinese monitoring center for oceans exploring collaboration Knowledge development in China is valuable for addressing environmental issues in Europe, and vice versa.
Technical files of silicone breast implants show shortcomings For medical devices such as breast implants, manufacturers are obliged to compile a ‘technical file’ based on which market authorization of the product will be decided.
Annual report 2015 RIVM online In our annual report, we look back at compelling RIVM projects and research in 2015.
Information about medicines more accessible to the user The Medicines Evaluation Board (MEB), the Netherlands Pharmacovigilance Centre (Lareb), the National Institute for Public Health and the Environment (RIVM), and the National Health Care Institute w
Average disease burden highest for invasive pneumococcal disease and influenza The average annual disease burden for the total Dutch population was highest for invasive pneumococcal disease and influenza.
Active monitoring period for Ebola ends for evacuated aid workers As 21 days have passed since the two aid workers evacuated from Sierra Leone had unprotected contact with Ebola patients, active monitoring of their health status by the Community Health Service ha
RIVM presents four scenarios on future public health at European Health Forum Gastein On the first day of the 17th European Health Forum Gastein (EHFG), the Dutch National Institute for Public Health and the Environment (RIVM) organises a workshop on ‘Our health in 2040’.
The two Dutch patients are not infected with Ebola virus The two patients, who have been admitted to the hospital under suspicion of an Ebola infection, are not infected with the virus.
Patient admitted for Ebola assessment On 22 September, following the request of the General Practitioner, a patient was transported to the Radboudumc in order to undergo further medical assessment.